{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2023"],"data_sharing_plan":["IPD Sharing (as of September 2023): No"],"condition":["Colon Cancer","Liver Metastasis Colon Cancer","Rectal Cancer","Colonic Neoplasms"],"disease":["Colon Cancer","Liver Metastasis Colon Cancer","Rectal Cancer","Colonic Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/107091"],"location":["Israel"],"study_start_month":["11"],"keyword":["Stereotactic ablative radiotherapy (SABR)","Immunotherapy","SBRT","Radiation","Radiotherapy"],"repository":["ECRIN MDR"],"study_status":["Not yet recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Hepatopulmonary Radio-sterilization With Immunotherapy","description":"In this protocol the investigators aim to overcome hepatic-pulmonary metastases-induced resistance to immunotherapy through high dose radiation therapy (SBRT) targeted to the metastases themselves, aiming, when possible, to ablate all macroscopic disease in these organs.","dates":{"creation":"2023-11-15"},"accession":"107091","cross_references":{"ClinicalTrials___gov":["NCT06053996"]}}